Last reviewed · How we verify
Roxane Laboratories Inc., USA
Roxane Laboratories Inc., USA's drug is a central nervous system stimulant.
Roxane Laboratories Inc., USA's drug is a central nervous system stimulant. Used for Attention deficit hyperactivity disorder.
At a glance
| Generic name | Roxane Laboratories Inc., USA |
|---|---|
| Sponsor | Thinq Pharma-CRO Pte. Ltd. |
| Drug class | Central nervous system stimulant |
| Modality | Small molecule |
| Therapeutic area | Attention deficit hyperactivity disorder |
| Phase | Phase 3 |
Mechanism of action
It works by increasing the levels of dopamine and norepinephrine in the brain, which helps to improve focus and attention.
Approved indications
- Attention deficit hyperactivity disorder
Common side effects
- Insomnia
- Anxiety
- Headache
- Nausea
- Dizziness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |